Cullinan Oncology (CGEM) Short Interest Ratio & Short Volume → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free CGEM Stock Alerts $27.72 -1.63 (-5.55%) (As of 05:26 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cullinan Oncology Short Interest DataCurrent Short Volume1,680,000 sharesPrevious Short Volume1,440,000 sharesChange Vs. Previous Month+16.67%Dollar Volume Sold Short$27.80 millionShort Interest Ratio / Days to Cover3.1Last Record DateApril 15, 2024Outstanding Shares43,070,000 sharesFloat Size26,340,000 sharesShort Percent of Float6.38%Today's Trading Volume1,031,716 sharesAverage Trading Volume620,902 sharesToday's Volume Vs. Average166% Short Selling Cullinan Oncology ? Sign up to receive the latest short interest report for Cullinan Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCGEM Short Interest Over TimeCGEM Days to Cover Over TimeCGEM Percentage of Float Shorted Over Time Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. Cullinan Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,680,000 shares $27.80 million +16.7%6.4%3.1 $16.55 3/31/20241,440,000 shares $24.54 million +53.9%5.5%3.4 $17.04 3/15/2024935,400 shares $14.90 million +34.8%3.6%2.3 $15.93 2/29/2024694,100 shares $12.82 million -11.5%2.6%1.8 $18.47 2/15/2024783,900 shares $14.45 million -46.7%2.9%2.3 $18.43 1/31/20241,470,000 shares $22.26 million +34.9%5.4%5.1 $15.14 Get the Latest News and Ratings for CGEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cullinan Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,090,000 shares $11.54 million +3.8%4.0%5.2 $10.59 12/31/20231,050,000 shares $10.70 million -48.5%3.9%5.4 $10.19 12/15/20232,040,000 shares $16.81 million -3.3%7.5%11.1 $8.24 11/30/20232,110,000 shares $17.28 million -2.3%7.8%12.5 $8.19 11/15/20232,160,000 shares $19.16 million +0.5%8.0%13.3 $8.87 10/31/20232,150,000 shares $20.06 million -1.8%7.9%12.9 $9.33 10/15/20232,190,000 shares $19.27 million -0.5%8.1%12.9 $8.80 9/30/20232,200,000 shares $19.91 million +0.9%8.1%12.1 $9.05 9/15/20232,180,000 shares $21.71 million -17.7%8.0%11.5 $9.96 8/31/20232,650,000 shares $27.43 million +33.2%9.8%10.2 $10.35 8/15/20231,990,000 shares $20.32 million +2.6%7.4%6.4 $10.21 7/31/20231,940,000 shares $20.54 million -18.5%8.2%6.1 $10.59 7/15/20232,380,000 shares $27.89 million +15.5%10.1%7.6 $11.72 6/30/20232,060,000 shares $22.17 million -11.6%8.7%6.8 $10.76 6/15/20232,330,000 shares $29.59 million +2.6%9.9%7.6 $12.70 5/31/20232,270,000 shares $23.34 million +0.9%9.6%8.6 $10.28 5/15/20232,250,000 shares $22.37 million +0.5%9.5%10.7 $9.94 4/30/20232,240,000 shares $21.80 million +0.5%9.5%10.7 $9.73 4/15/20232,230,000 shares $22.34 million +0.5%9.5%9.9 $10.02 3/31/20232,220,000 shares $22.71 million +1.8%9.4%10.2 $10.23 3/15/20232,180,000 shares $24.44 million +3.8%7.7%10.5 $11.21 2/28/20232,100,000 shares $23.71 million +1.5%7.0%13.3 $11.29 2/15/20232,070,000 shares $23.91 million +6.7%6.9%13.7 $11.55 1/31/20231,940,000 shares $22.58 million -9.4%6.6%13.7 $11.64 1/15/20232,140,000 shares $23.50 million -1.8%7.2%16.4 $10.98 12/30/20222,180,000 shares $23.00 million No Change7.4%17 $10.55 12/15/20222,180,000 shares $24.96 million No Change7.4%15.9 $11.45 11/30/20222,180,000 shares $27.10 million -5.6%7.4%14.8 $12.43 11/15/20222,310,000 shares $29.48 million -4.9%8.0%14.2 $12.76 10/31/20222,430,000 shares $31.93 million -0.4%8.5%15.4 $13.14 10/15/20222,440,000 shares $30.79 million -1.2%8.5%15.7 $12.62 9/30/20222,470,000 shares $31.67 million +14.4%8.6%14.2 $12.82 9/15/20222,160,000 shares $28.21 million -13.6%7.5%10.9 $13.06 8/31/20222,500,000 shares $33.70 million No Change8.8%10.5 $13.48The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read CGEM Short Interest - Frequently Asked Questions What is Cullinan Oncology's current short interest? Short interest is the volume of Cullinan Oncology shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,680,000 shares of CGEM short. 6.38% of Cullinan Oncology's shares are currently sold short. Learn More on Cullinan Oncology's current short interest. What is a good short interest ratio for Cullinan Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEM shares currently have a short interest ratio of 3.0. Learn More on Cullinan Oncology's short interest ratio. Which institutional investors are shorting Cullinan Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cullinan Oncology: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cullinan Oncology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.38% of Cullinan Oncology's floating shares are currently sold short. Is Cullinan Oncology's short interest increasing or decreasing? Cullinan Oncology saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,680,000 shares, an increase of 16.7% from the previous total of 1,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cullinan Oncology's float size? Cullinan Oncology currently has issued a total of 43,070,000 shares. Some of Cullinan Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cullinan Oncology currently has a public float of 26,340,000 shares. How does Cullinan Oncology's short interest compare to its competitors? 6.38% of Cullinan Oncology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Cullinan Oncology: Vir Biotechnology, Inc. (5.79%), Scholar Rock Holding Co. (15.91%), 4D Molecular Therapeutics, Inc. (19.21%), Tarsus Pharmaceuticals, Inc. (20.91%), BioCryst Pharmaceuticals, Inc. (16.67%), Autolus Therapeutics plc (1.53%), Xencor, Inc. (10.09%), MacroGenics, Inc. (14.65%), Neumora Therapeutics, Inc. (11.07%), ADMA Biologics, Inc. (3.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cullinan Oncology stock? Short selling CGEM is an investing strategy that aims to generate trading profit from Cullinan Oncology as its price is falling. CGEM shares are trading down $1.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cullinan Oncology? A short squeeze for Cullinan Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEM, which in turn drives the price of the stock up even further. How often is Cullinan Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VIR Short Interest Data SRRK Short Interest Data FDMT Short Interest Data TARS Short Interest Data BCRX Short Interest Data AUTL Short Interest Data XNCR Short Interest Data MGNX Short Interest Data NMRA Short Interest Data ADMA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CGEM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings